The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James) is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James) has participated in 4 clinical trials with 2 currently active.
Therapeutic areas: Hepatocellular Carcinoma, Metastatic Melanoma, Metastatic Adenocarcinoma of the Pancreas.
Sponsors: Coherus Oncology, Inc., Idera Pharmaceuticals, Inc., Ipsen.
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James) has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James) has 4 clinical trials on record, with 2 currently active. Their work covers Hepatocellular Carcinoma, Metastatic Melanoma, Metastatic Adenocarcinoma of the Pancreas.
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.